glp-1 peptides receptor agonists show promise in treating substance use disorders raised bovine GLP-1 (S) Vial (GLP-1 Analogue)
Description
Retrieved from iData Research: Sung, A
No SAEs were reported, and none of the AEs led to premature treatment discontinuation
These drugs are taken long-term
At this stage, the primary goal is to allow the body to adjust to the medication and minimise gastrointestinal side effects
